Is Angi, Inc. overvalued or undervalued?

As of 3 September 2025, the valuation grade for Angi, Inc. has moved from fair to attractive, indicating a positive shift in its perceived value. The company appears to be undervalued based on several key metrics, including a P/E ratio of 16, a Price to Book Value of 0.81, and an EV to EBITDA ratio of 8.45. Compared to peers, Angi, Inc. has a more favorable P/E ratio of approximately 14.77, while GoodRx Holdings, Inc. is at 31.76, highlighting Angi's relative attractiveness.
Despite not having recent return data available for comparison, the overall valuation metrics suggest that Angi, Inc. is positioned well within its industry, particularly against struggling peers like Sharecare, Inc. and Nextdoor Holdings, Inc., which are both classified as risky. This reinforces the notion that Angi, Inc. is undervalued in the current market landscape.